论文部分内容阅读
为了观察用76％复方泛影葡胺子宫造影的效果，本文对41例恶性滋养细胞肿瘤患者进行了观察，发现该药显影迅速，对比度清晰，注射后无任何反应，安全性大。其中11例行子宫全切术，1例行病灶挖除术，术后病理与诊断相符合。敢用76％复方泛影葡胺子宫造影对确立诊断帮助很大，其效果同40％的碘化油，且无付作用。41例中同时作B超者30例，符合诊断者22例，占73．43％；应用彩色多普勒血流显像技术观察恶性滋养细胞肿瘤患者27例，22例符合，符合率达81．48％。所以，除详询病史及血绒毛膜促性腺激素（HCG）测定外，用子宫造影，B超，彩色多普勒血流显像技术联合应用有助于恶性滋养细胞肿瘤的早期诊断。
In order to observe the effect of 76% compound megluminemic uterine angiography, 41 cases of malignant trophoblastic tumor patients were observed and found that the drug developed rapidly, the contrast was clear, no response after injection, safety. Among them, 11 patients underwent hysterectomy and 1 patient underwent excision of the lesions. The postoperative pathology was consistent with the diagnosis. Dare to use 76% compound meglumine diatrizoate uterine angiography to help establish a great diagnosis, the effect of 40% iodized oil, and no pay role. Totally, 41 cases were diagnosed as B-ultrasonography in 30 cases, accounting for 73.43%. The color Doppler flow imaging technique was used to observe 27 cases of malignant trophoblastic tumor, and the coincidence rate was 81 .48%. Therefore, in addition to detailed history and blood chorionic gonadotropin (HCG) determination, with uterine angiography, B ultrasound, color Doppler flow imaging techniques combined with the help of early diagnosis of malignant trophoblastic tumors.